USA flag logo/image

An Official Website of the United States Government

Rapid Method for the Quantification of Exo-Erythrocytic (Liver-stage) Malaria…

Award Information

Agency:
Department of Defense
Branch:
Army
Award ID:
63083
Program Year/Program:
2003 / SBIR
Agency Tracking Number:
A022-1339
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
MD BIOTECH, INC.
511 Burrough St. Morgantown, WV 26505
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2003
Title: Rapid Method for the Quantification of Exo-Erythrocytic (Liver-stage) Malaria Parasites
Agency / Branch: DOD / ARMY
Contract: DAMD17-03-C-002
Award Amount: $65,333.00
 

Abstract:

Manual quantification of the malaria parasite is time consuming, costly and inhibits vaccine and drug development. The objective of this Phase I SBIR is to develop and validate an image capture, documentation and quantification technology to score theinvasion of malarial parasites in hepatoma cells. The quantitative image analysis software will be designed as to provide the basis of a fully automated microscopy technology. Technical innovations incorporated in this proposal include, 1) a digitalimaging system for the capture and documentation of malarial parasites in hepatoma cells, 2) technology for the scoring of the number of malarial parasite invasion and 3) the transition to a fully automated microscopy system that eliminates userinvervention and provides high-throughput screening capability.MD Biotech has experience in developing high-throughput automated microscopy systems for the pharmaceutical industry. The Automated Comet Assay System is an exapmle of MD Biotech's abilities.The proposed detection technology and transition to an automated microscopy system meets the critical need within the malarial vaccine and drug development programs to increase assay throughput, relieve technical personnel from hours of tedious microscopeviewing, remove scoring bias and eliminate errors due to scorer fatigue or inconsistant application of scoring criteria. Commercial applications of this proposed research include improved imaging, scoring and automation of the envasion of parasites andinfectious agents within various mammalian cells. This technology has direct applications in vaccine research, preclinical drug screening and other numerous cell based assays.

Principal Investigator:

Christopher J. Kolanko
Chief Scientist
3045981134
chriskolanko@mdbiotechinc.com

Business Contact:

Robert E. Kolanko
Chief Finacial Officer
3045981101
bobkolanko@mdbiotechinc.com
Small Business Information at Submission:

MD BIOTECH, INC.
511 Burrough St. Morgantown, WV 26505

EIN/Tax ID: 559783078
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No